Doctors are urging younger individuals and non-smokers to be vigilant about potential signs of lung cancer, emphasizing that the disease can progress silently and often goes undetected until it reaches an advanced stage. Medical professionals report that many patients with early symptoms are initially treated with repeated courses of antibiotics, sometimes at their own insistence to avoid missing work or due to time constraints, especially when caring for young children. By the time these patients receive a proper diagnosis, the cancer has often metastasized.

Lung cancer among non-smokers frequently presents as adenocarcinoma, a type that originates from glandular cells in the lung. This form typically develops in the lung’s outer areas, where tumors can grow without causing immediate irritation to the larger airways, allowing symptoms to remain unnoticed for longer periods. For some, the initial sign may be breathlessness caused by pleural effusion—fluid accumulation around the lungs. Even physically fit individuals can accumulate a significant amount of fluid before experiencing noticeable breathlessness.

While smoking remains the primary known risk factor for lung cancer, other causes are implicated in cases involving non-smokers. Research identifies air pollution as a contributing factor, accounting for approximately 8% of lung cancer cases in the United Kingdom. A study published last year also found that never-smokers exposed to higher levels of air pollution exhibited more cancer-related genetic changes in lung tumors. Additional risk factors include exposure to second-hand smoke, asbestos, and radon—a naturally occurring radioactive gas that may build up in buildings. However, in many cases, no clear cause is identified. Notably, women who have never smoked appear to be over twice as likely to develop lung cancer as never-smoking men, though the reasons for this disparity remain uncertain.

Under national health service guidelines, 85% of cancer patients should start treatment within 62 days following an urgent suspected cancer referral—a target that has consistently been unmet in recent years. Experts caution that even this timeframe might be too lengthy for some patients, as delays between symptom onset and treatment increase the risk of cancer spreading and potentially transitioning from a curable to an incurable stage. Approximately 40% of patients referred under the urgent lung cancer pathway do not begin treatment within the recommended period.

Healthcare providers also highlight the stigma associated with lung cancer, which can discourage patients from seeking timely medical help. Some individuals may be reluctant to report symptoms due to assumptions that the disease results solely from smoking or may underreport their smoking history, complicating diagnosis and treatment decisions. Physicians stress that understanding smoking history is important for determining the best treatment approach but emphasize that the focus should be on helping patients regardless of past behaviors.

Advances in lung cancer treatment, including targeted therapies and immunotherapies, have significantly improved patient outcomes compared to previous decades when survival was typically measured in months. Now, many patients live for years following diagnosis, provided they receive accurate diagnoses and prompt care.

Medical professionals underscore the importance of awareness, urging anyone experiencing persistent symptoms not to ignore them or assume they are too young to be at risk. Early evaluation and intervention remain critical for improving survival chances in lung cancer.